Third Rock Ventures V L.P. 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:15 pm Purchase |
2024-12-31 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP |
Third Rock Ventures V L.P. | 7,135,233 19.500% |
7,135,233 (New Position) |
Filing |